1. Son, Ju A, Ahn, Hye Ri, You, Donglim, Eun, Jung Woo, Cheong, Jae Youn. 2022. Novel Gene Signatures as Prognostic Biomarkers for Predicting the Recurrence of Hepatocellular Carcinoma. In Cancers, 14, . doi:10.3390/cancers14040865. https://pubmed.ncbi.nlm.nih.gov/35205612/
2. Hart, P E, Poynter, G M, Whitehead, C M, Barrett, S L, Salisbury, J L. . Characterization of the X-linked murine centrin Cetn2 gene. In Gene, 264, 205-13. doi:. https://pubmed.ncbi.nlm.nih.gov/11250075/
3. Qiu, Pei-Yuan, Deng, Xi-Han, Li, Li. 2022. High expression of CETN2 is associated with platinum resistance and poor prognosis in epithelial ovarian cancer. In Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 25, 1340-1352. doi:10.1007/s12094-022-03031-2. https://pubmed.ncbi.nlm.nih.gov/36527574/
4. Ying, Guoxin, Frederick, Jeanne M, Baehr, Wolfgang. 2019. Deletion of both centrin 2 (CETN2) and CETN3 destabilizes the distal connecting cilium of mouse photoreceptors. In The Journal of biological chemistry, 294, 3957-3973. doi:10.1074/jbc.RA118.006371. https://pubmed.ncbi.nlm.nih.gov/30647131/
5. Ying, Guoxin, Avasthi, Prachee, Irwin, Mavis, Lucero, Mary T, Baehr, Wolfgang. . Centrin 2 is required for mouse olfactory ciliary trafficking and development of ependymal cilia planar polarity. In The Journal of neuroscience : the official journal of the Society for Neuroscience, 34, 6377-88. doi:10.1523/JNEUROSCI.0067-14.2014. https://pubmed.ncbi.nlm.nih.gov/24790208/
6. Anurag, Meenakshi, Punturi, Nindo, Hoog, Jeremy, Ellis, Matthew J, Haricharan, Svasti. 2018. Comprehensive Profiling of DNA Repair Defects in Breast Cancer Identifies a Novel Class of Endocrine Therapy Resistance Drivers. In Clinical cancer research : an official journal of the American Association for Cancer Research, 24, 4887-4899. doi:10.1158/1078-0432.CCR-17-3702. https://pubmed.ncbi.nlm.nih.gov/29793947/
智鼠故事 
